Celularity Inc. Class A Common Stock

CELUNASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
1.32 USD
↗ 0.08 (6.53%)🟢LIVE (AS OF 01:16 PM EDT)
🟢Market: OPEN

CELU is currently priced at $1.32. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (241.3%) and a bearish Death Cross on the long-term moving averages. On the valuation side, CELU appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Sep 15, 2026.

Open?$1.26
High?$1.36
Low?$1.14
Prev. Close?$1.24
Volume?127.5K
Avg. Volume?8.2M
VWAP?$1.27
Rel. Volume?0.02x
Bid / Ask
Bid?$1.34 × 100
Ask?$1.40 × 100
Spread?$0.06
Midpoint?$1.37
Valuation & Ratios
Market Cap?35.9M
Shares Out?28.9M
Float?7.3M
Float %?25.1%
P/E Ratio?N/A
P/B Ratio?-0.94
EPS?-$3.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Themes
Healthcare - Oncology›Cell & Gene Therapy for CancerBiotech - Drug Development›Clinical-Stage Platforms
Employees
115
Market Cap
35.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.celularity.com
Listed
2021-07-19
Address
170 PARK AVE
FLORHAM PARK, NJ 07932
Phone: (908) 768-2170
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
10
Short Sent.?
25
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.19Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?26.11%Squeeze Risk
Short Interest?1.9M
Days to Cover?1.0
Free Float7.3M
Avg Daily Volume21.8M
Settlement Date2026-08-31
Financial Health
Current Ratio?0.15Weak
Quick Ratio?0.15Weak
Cash Ratio?0.08Low
Debt/Equity?-1.26Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.94CHEAP▾
P/S?
Peers
100
S&P
81
1.35CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
Peers
100
S&P
62
2.92CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
241.3%STRONG▾
ROA?
S&P
3
-85.6%WEAK▾
Cash Flow & Enterprise
FCF?$-13254000
Enterprise Value?$77.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist